Inverse correlation between serum levels of selenoprotein p and adiponectin in patients with type 2 diabetes

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Misu, Hirofumi ^a   Ishikura, Kazuhide ^a   Kurita, Seiichiro ^a   Takeshita, Yumie ^a   Ota, Tsuguhito ^a   Saito, Yoshiro ^b   Takahashi, Kazuhiko ^c   Kaneko, Shuichi ^a   Takamura, Toshinari ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

^c HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; GLUCOSE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SELENOPROTEIN P; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ADIPOQ PROTEIN, HUMAN; INSULIN;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; AGE; ANIMAL CELL; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOREACTIVITY; INSULIN SENSITIVITY; LIPID DIET; LIVER FUNCTION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN BLOOD LEVEL; UPREGULATION; AGED; ANIMAL; BLOOD; DIET RESTRICTION; GENETICS; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MOUSE MUTANT; PHYSIOLOGY; SUGAR INTAKE;

MUS;

ADIPONECTIN; AGED; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DIETARY SUCROSE; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; SELENOPROTEIN P;

EID: 84859327136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034952     Document Type: Article

References (32)

1. Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, et al. (2010) A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 12: 483-495.
2. Carlson BA, Novoselov SV, Kumaraswamy E, Lee BJ, Anver MR, et al. (2004) Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J Biol Chem 279: 8011-8017.
3. Hill KE, Zhou J, McMahan WJ, Motley AK, Atkins JF, et al. (2003) Deletion of selenoprotein P alters distribution of selenium in the mouse. J Biol Chem 278: 13640-13646.
4. Schomburg L, Schweizer U, Holtmann B, Flohe L, Sendtner M, et al. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 370: 397-402.
5. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8: 731-737.
6. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
7. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, et al. (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106: 2767-2770.
8. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468.
9. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G, (2003) Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52: 1779-1785.
10. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
11. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, et al. (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52: 239-243.
12. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, et al. (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51: 1884-1888.
13. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, et al. (2005) Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54: 534-539.
14. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, et al. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. Jama 291: 1730-1737.
15. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, et al. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085.
16. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, et al. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278: 40352-40363.
17. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, et al. (2006) Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 91: 3873-3877.
18. Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, et al. (2006) Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and-independent pathways. J Biol Chem 281: 8748-8755.
19. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, et al. (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52: 1655-1663.
20. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, et al. (2011) Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. The Journal of clinical endocrinology and metabolism 96: E1325-1329.
21. Walter PL, Steinbrenner H, Barthel A, Klotz LO, (2008) Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor. Biochemical and biophysical research communications 365: 316-321.
22. Speckmann B, Walter PL, Alili L, Reinehr R, Sies H, et al. (2008) Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors. Hepatology 48: 1998-2006.
23. Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, et al. (2010) Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest 120: 4220-4235.
24. Lumeng CN, Saltiel AR, (2011) Inflammatory links between obesity and metabolic disease. The Journal of clinical investigation 121: 2111-2117.
25. Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF, (1996) Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J Nutr 126: 138-145.
26. Yang JG, Hill KE, Burk RF, (1989) Dietary selenium intake controls rat plasma selenoprotein P concentration. J Nutr 119: 1010-1012.
27. Burk RF, Hill KE, (2005) Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 25: 215-235.
28. Andoh A, Hirashima M, Maeda H, Hata K, Inatomi O, et al. (2005) Serum selenoprotein-P levels in patients with inflammatory bowel disease. Nutrition 21: 574-579.
29. Persson-Moschos M, Alfthan G, Akesson B, (1998) Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium. Eur J Clin Nutr 52: 363-367.
30. Saito Y, Watanabe Y, Saito E, Honjoh T, Takahashi K, (2001) Production and application of monoclonal antibodies to human selenoprotein P. Journal of Health Science 47: 346-352.
31. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410.
32. Misu H, Takamura T, Matsuzawa N, Shimizu A, Ota T, et al. (2007) Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 50: 268-277.